![John Byon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 407 $ al 31/05/2026
John Byon currently works at Imugene Ltd., as Chief Medical Officer from 2025.
Dr. Byon also formerly worked at Fate Therapeutics, Inc., as Vice President-Clinical Development.
Dr. Byon received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from Tulane University (Louisiana).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMUGENE LTD 0,02 % | 30/06/2025 | 65.348 ( 0,02 % ) | 5 407 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMUGENE LIMITED | Director Técnico/Científico/I+D | 01/09/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
